The epigenetics orchestra of Notch signaling: a symphony for cancer therapy

Alireza Paniri1,2, Mohammad Mahdi Hosseini3, Fatemeh Amjadi-Moheb1

  • 1Department of Genetics, Faculty of Medicine, Babol University of Medical Sciences, Babol, 4717647745,Iran.

Epigenomics
|December 19, 2023
PubMed

Insights

Aberrant Notch signaling is linked to cancer. Epigenetic modifications offer new therapeutic strategies for Notch pathway-targeted cancer treatments.

Area of Science:

  • Cellular signaling
  • Cancer biology
  • Epigenetics

Background:

  • The Notch signaling pathway is crucial for development and its dysregulation is implicated in various human cancers.
  • Notch pathway activity can promote or suppress tumors, depending on the cellular context.
  • Epigenetic modifications can influence Notch pathway signaling.

Purpose of the Study:

  • To review the regulatory mechanisms of Notch signaling.
  • To explore the therapeutic potential of targeting Notch signaling through epigenetic modifications.

Main Methods:

  • Literature review of Notch signaling pathways.
  • Analysis of epigenetic modifications affecting Notch ligands and receptors.
  • Discussion of therapeutic strategies targeting the Notch pathway.

Main Results:

  • The Notch pathway's dual role as an oncogene or tumor suppressor is context-dependent.
  • Epigenetic mechanisms provide a means to modulate Notch signaling.
  • Targeting epigenetic regulation offers potential for novel cancer therapies.

Conclusions:

  • Understanding Notch signaling regulation is key to developing effective cancer treatments.
  • Epigenetic-based therapeutics targeting the Notch pathway hold promise for single and combination treatments.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K